• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    A sampler device (10) having recessed portions (16) and sheath (14) is useful for collecting a sample of a biological material, especially feces for carrying out analytical tests.
    公开号:SU1475493A3
    申请号:SU823458455
    申请日:1982-05-21
    公开日:1989-04-23
    发明作者:Швартц Самюель
    申请人:Риджентс Оф Дзе Юниверсити Оф Миннесота (Фирма)；
    IPC主号:
    专利说明:


    The invention relates to medicine, in particular to methods for determining the concentration of hemoglobin in faeces.
    The purpose of the invention is to improve the accuracy and acceleration of the method.
    The goal is achieved by converting non-fluorescent hemoglobin to porphyrin when heated in the presence of oxalic acid and iron oxalate, the resulting porphyrin is determined by fluorescence analysis in the extract. At an excitation wavelength of 408-410 nm and emission of 660 nm, the amount of non-specific fluorescence is determined in a separate sample wherein citric acid or another similar non-reactive compound replaces the oxalic acid-iron oxalate system. By subtracting the amount of fluorescence obtained in citric acid from the value found for the sample to be analyzed, the value of fluorescence is obtained, which is associated with porphyrin derived from hemoglobin.
    Figure 1 shows the fluorescence spectrum of the gel-like reaction mixture (oxalic acid: iron oxalate) with and without the addition of hemoglobin; figure 2 - the second derivative of the fluorescence spectrum; FIG. 3 is a graph comparing the fluorescence spectra of hemoglobin in a solution of oxalic acid — oxalate of iron and hemoglobin in a solution of citric acid (in the vertical direction - levels of fluorescence,
    Съ СЛ Ј
    WITH
    SLE
     Sh
    3147549
    horizontally - emission wavelengths); Fig. 4 is a graph comparing the fluorescence spectrum of a sample of faeces in an oxalic acid-oxa-, lats iron solution with a spectrum of the same sample in a solution of citric acid; FIG. 5 shows a linear relationship between the level of hemoglobin and fluorescence in a schawedeva acid JQ m solution — iron oxalate, to which iron is added in the form of FeSO. (on the abscissa axis - hemoglobin concentration, on the ordinate axis - the level of fluorescence) .15
    The method is carried out as follows.
    The definition is composed of three stages. The first involves the preparation of a test sample of faeces, the second - 20 quantitative transformation of the sample hemoglobin into fluorescent porphyrin, the third - measurement of the fluorescence of porphyrin in the test sample and in t
    In Figure 5, the concentration of hemoglobin treated in the autoclave is set aside depending on the fluorescence intensity for the concentration of ferrous sulfate: 0.0%; 0.1%; 1.0% and 3.0%. As can be seen, curve 1, obtained without FeSO, is non-linear at high concentrations of hemoglobin, and curve 2 in the presence of FeSO is linear. Figure 5 A vozb. 410 nm, and 1 isp. 660 nm. Samples are diluted before fluorescence analysis until the color disappears.
    After being converted to protoporphyrin, the mixture is allowed to cool. Then a 4: 1 solution containing ethyl acetate and glacial acetic acid, taken in a 1:12 ratio, is added to it. The resulting mixture was centrifuged. For fluorescence analysis, the supernatant is used, which due to the addition of ethyl acetate and “glacial acetic acid”
    a blank sample (in which 25 is used is transparent
    oxalic acid instead of a mixture. Spectrofluorimetry is carried out
    on Amco's devices Bowman or
    Perkhin Elmer (for example, Perkhin Elmer
    model MPF-44B). 2Q As a blank solution,
    to take into account the presence of iron druoxalate, citric acid in the sample) and compare the difference in fluorescence with the control standard of a known hemoglobin concentration.
    First, the test is taken and weighed.
    Toxic amount of faecal sample - 0.5 g. 20-40 ml of 0.85% sodium chloride is added to the sample, the mixture is homogenized until a uniform dispersion of feces. The obtained test sample is stored in a frozen state at a temperature of (-15) to (-30 ° C) until claimed. Material concentration 2.5%.
    The test sample is then mixed with a reaction mixture containing 0.3-3% ferrous sulphate or 1% ferrous oxalate in 2M oxalic acid at a volume ratio of homogenized material: 1:20 reaction mixture. The resulting mixture is heated until the ingredients dissolve (120 ° C for 90 minutes). The addition of oxalate or sulphate of iron, which act as additional reducing agents (along with oxalic acid), ensures that the hemoglobin theme is completely transformed into porphyrin and this provides a straightforward graph of fluorescence in the hemoglobin concentration range sufficient for all possible levels of hemoglobin. faeces x (figure 5).
    five
    0
    55
    45
    fluorescent substances, a test sample is used, in which bold acid and oxalate, Fe2 sulfate is replaced by 1.5 M citric acid, the remaining procedures are identical to those described for the analyzed test sample, since in the presence of citric acid there is no transformation The amount of subject (less than 0.2%) in porphyrin, the resulting blank test sample allows to estimate the base level of porphyrins in feces.
    Figures 3 and 4 show the fluorescence spectra of both mixtures with citric acid and oxalic acid – oxalate mixture Fe42.

    Fig. 3 shows the fluorescence spectrum of the added hemoglobin in the oxalic acid – Fe24 oxalate system — curve 1 and the fluorescence spectrum (curve 2) of the added hemoglobin in the citric acid system.
    Figure 4 shows the fluorescence spectrum (1) of a sample of faeces with hemoglobin in the system oxalic acid-oxalate and fluorescence spectrum
    (2) the same sample in the citric acid blank system.
    Thus, the fluorescence difference between spectra 1 and 2 reflects the amount of transformed porphyrin in the faecal sample under study.
    EXAMPLE 1 A 2.5% fecal homogenate is prepared in a 0.85% NaCl solution. Then prepare 100 g of the reaction mixture, combining 25.2 g of oxalic acid, 1.0 g of Fe04 powder or Fe + oxalate in
    73.8ml of water. These ingredients are heated in a boiling water bath to dissolve (100-120 ° C). Reaction v. the mixture is poured into tubes or ampoules, which are sealed and stored at -30 ° C
    before use. Also prepare 100 g of the control blank mixture, combining 28.8 g of citric acid and
    71.9ml of water. Further, 50 ml of the 2.5% homogenate is added to each of the tubes in which the analysis is carried out. 1.0 ml of either an oxalic acid – ocadate mixture or a blank mixture is added thereto. The tubes are mixed in a centrifuge covered with a wound film with openings in the top. Then the tubes are heated in an autoclave for 90 minutes at
    120 ° C is allowed to cool, extraction is carried out with ethyl acetate as previously described and fluorescence is measured, since protoporphyrin is about 3.37% of the molecular weight of hemoglobin, the values obtained for porphyrin are multiplied by 100 / 3.37 or 29.67 to obtain an appropriate hemoglobin value. The hemoglobin value is then determined in milligrams per gram of feces by multiplying by the appropriate dilution factors.
    Example 2 To preserve the reaction mixture, polyethylene glycol was further added to it in the following ratio of components: 73.8 g of polyethylene glycol; 25.2 g of oxalic acid, 1.0 g of oxalate powder or 1.0 g of Fe + 2 sulphate.
    71.2 g of polyethylene glycols and 28.8 g of citric acid are added to the blank mixture. The above mixtures give concentrations of 4 M oxalic acid and 1.5 M citric acid, respectively.
    five
    0
    50
    (- 0
    five
    five
    To obtain the expected result, 70% or 75% polyethylene oxide can be used.
    When analyzing the spectra of the gel-like reaction mixture, the use of second derivatives of the fluorescence spectra can provide significant advantages (Figures 1 and 2).
    权利要求:
    Claims (4)
    [1]
    Invention Formula
    .one . The method for determining hemoglobin concentration in faeces by obtaining a suspension of the material under study, converting the hemoglobin theme into porphyrin in the presence of oxalic acid and a reducing salt, followed by changing the fluorescence of the obtained sample, in order to improve the accuracy and speed up the method, the suspension is obtained by homogenization in a solution of 0.85% sodium chloride at a material concentration of 2.5%, then the homogenized material is introduced into the reaction mixture containing 0.3-3% sulphate bivalent iron or 1% ferrous oxalate in 2 M oxalic acid at a volume ratio of homogenized material: 1:20 reaction mixture, the resulting mixture is heated to dissolve the ingredients and a solution containing 4: 1 ethyl acetate and glacial acetic acid is added to it , taken in a ratio of 1:12, and in the upper layer of the mixture, fluorescence is measured at 660 nm and the length of the exciting light is 408-410 nm.
    [2]
    2. Method of claim 1, characterized in that the conversion of the hemoglobin theme of the test sample to porphyrin is carried out in a reaction mixture containing polyethylene glycol or polyethylene oxide in a concentration of 70-75%.
    [3]
    3. The method according to claim 1 or 2, about t l and - h. The test sample is combined with oxalic acid, or oxalate, or ferrous sulfate at 100-120 ° C.
    [4]
    4 .. The method according to claims 1 to 3, which is tl and c by the fact that the step of measuring the fluorescence of the transformed porphyrin includes measuring fluo-; resection of the test sample, in which the hemoglobin heme is turned into porphyrin, fluorescence measurement
    1j1
    & ride $ a8ki hemoglobin (with do5a8koy hemoglobin
    550 600650
    Wavelength of emission, nm. FIG. one
    2,000
    With da5a8koy hemoelo5ina
    Length of wavelength, nm Thebes. Z
    I
    I
    t
    t but
    Length of emission, nm
    oh t looo
    Concentration of hemovloyaine, mc / ml of solution fie.5
    one
    600 550 Wavelength of emission, nor FIG. : H
    类似技术:
    公开号 | 公开日 | 专利标题
    SU1475493A3|1989-04-23|Method of determining hemoglobin concentration in feces
    Thomas et al.1978|Fluorescence energy transfer in the rapid-diffusion limit
    FI72611B|1987-02-27|BLANDNING SOM LAEMPAR SIG FOER TESTNING AV BIOLOGISKA VAEVNADER OCH / ELLER VAETSKOR OCH FOERFARANDE FOER ANVAENDNING AV DENNA BLANDNING.
    EP0694164A4|1994-06-22|Method for optically measuring chemical analytes
    Duchowicz et al.1998|Kinetic spectroscopy of erythrosin phosphorescence and delayed fluorescence in aqueous solution at room temperature
    Cripps et al.1967|Fluorescing erythrocytes and porphyrin screening tests on urine, stool, and blood: Investigation of photosensitivity
    Horvath et al.1992|Salting-out surfactant extraction of porphyrins and metalloporphyrin from aqueous non-ionic surfactant solutions
    US4018530A|1977-04-19|Fluorescence spectrometry employing excitation of bleaching intensity
    CA1186621A|1985-05-07|Fluoro immuno assay system
    US4539180A|1985-09-03|Apparatus for quantitatively determining the level of hemoglobin in a biological sample
    US4526869A|1985-07-02|Method for quantitatively determining the concentration of hemoglobin in a biological sample
    FI76434C|1988-10-10|A method for determining the hemoglobin level in a biological sample
    Montero et al.1990|Fluorescence quenching of albumin. A spectrofluorimetric experiment
    Lipowska et al.1993|A highly selective hydrogen‐deuterium exchange in indolium heptamethine cyanines
    Sasaki et al.1982|Nature of serum ascorbate radical and its quantitative estimation
    US3348920A|1967-10-24|Reagent and method for the quantitative determination of bilirubin
    RU2157531C1|2000-10-10|Method for determining total antioxidation activity of the blood
    Miller et al.1978|Porphyrins in muscle and red bone marrow of beef
    Pavon et al.1990|Simultaneous determination of gallium and aluminium in biological samples by conventional luminescence and derivative synchronous fluorescence spectrometry
    SU1138741A1|1985-02-07|Method of differentiating time elapsed since blood stain formation
    SU1165995A1|1985-07-07|Method of determining 1,8 anthraquinone dioxide
    SU908322A1|1982-02-28|Device for determining iron in blood serum
    Saito et al.1994|Sensitive Spectrofluorometric Method for the Determination of Human Serum Albumin with Tetrakis | porphine
    RU2006024C1|1994-01-15|Pyrazidol determination method
    Brain et al.1949|The estimation of trichloroethylene in blood
    同族专利:
    公开号 | 公开日
    EP0060868A4|1983-02-09|
    RO85158A|1984-09-29|
    IL63878A|1985-09-29|
    JPS57501746A|1982-09-24|
    IT1139490B|1986-09-24|
    EP0060868B1|1987-04-08|
    ZA816471B|1982-11-24|
    FI73839C|1987-11-09|
    DK222682A|1982-05-17|
    US4378971A|1983-04-05|
    HU195005B|1988-03-28|
    RO85158B|1984-10-30|
    EP0060868A1|1982-09-29|
    BE890487A|1982-01-18|
    AU4914585A|1986-03-13|
    JPH0241708B2|1990-09-19|
    EP0187684A2|1986-07-16|
    AU7643581A|1982-04-14|
    IT8124138D0|1981-09-24|
    BR8108803A|1982-08-24|
    IL63878D0|1981-12-31|
    EP0187684A3|1986-12-03|
    FI73839B|1987-07-31|
    FI821798A0|1982-05-20|
    DE3176093D1|1987-05-14|
    AU571750B2|1988-04-21|
    MX153850A|1987-01-23|
    AU548846B2|1986-01-02|
    WO1982001070A1|1982-04-01|
    NZ198372A|1984-11-09|
    CA1178876A|1984-12-04|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    NL126365C|1963-06-24|
    US3400708A|1965-11-24|1968-09-10|Robert A. Scheidt|Cytologic endocrine evaluation device|
    GB1173267A|1968-06-12|1969-12-03|Robert Anthony Scheidt|Cytologic Endocrine Evaluatin Device|
    US3713985A|1970-10-19|1973-01-30|Kantor F|Device and method for testing potency of biological control reagents|
    GB1366556A|1971-03-12|1974-09-11|Res Ind Corp|Cervical sampling apparatus|
    US3877464A|1972-06-07|1975-04-15|Andrew R Vermes|Intra-uterine biopsy apparatus|
    US3777743A|1972-09-29|1973-12-11|Kendall & Co|Endometrial sampler|
    US4056359A|1973-04-10|1977-11-01|American Home Products Corporation|Profile recognition apparatus for identifying bacteria|
    DE2422260B2|1974-05-08|1979-04-12|Compur-Electronic Gmbh, 8000 Muenchen|Device for the production of a measuring liquid to be optically examined|
    GB1503264A|1975-03-29|1978-03-08|Battelle Institut E V|Swabs for and methods of taking cell smears for diagnostic examination|
    US4027658A|1975-12-01|1977-06-07|Manly Ernest Marshall|Instrument for taking samples|
    US4260392A|1978-07-07|1981-04-07|Technicon Instruments Corporation|Method and apparatus for obtaining an aliquot of a liquid in a gel medium|US4567148A|1980-09-24|1986-01-28|Regents Of The University Of Minnesota|Method for quantitatively determining the amount of hemoglobin in a biological sample|
    US4526869A|1980-09-24|1985-07-02|Regents Of The University Of Minnesota|Method for quantitatively determining the concentration of hemoglobin in a biological sample|
    US4615982A|1984-12-11|1986-10-07|Lawrence Paul J|Fecal occult blood test|
    US4801655A|1985-06-21|1989-01-31|Gould, Inc.|Fiber optic pH sensor having low drift rate|
    US4847050A|1985-07-22|1989-07-11|E. I. Du Pont De Nemours And Company|Resealable lid structure for a container|
    US4818702A|1986-06-02|1989-04-04|Litmus Concepts, Inc.|Fecal occult blood test reagent|
    US5182191A|1988-10-14|1993-01-26|Pacific Biotech, Inc.|Occult blood sampling device and assay|
    JPH0525358U|1991-09-17|1993-04-02|東洋製罐株式会社|Sample inspection tool|
    JPH0550109U|1991-12-05|1993-07-02|エスエムシー株式会社|Rodless cylinder|
    JP2755021B2|1992-03-04|1998-05-20|三菱自動車工業株式会社|Valve train for internal combustion engine|
    JPH062228U|1992-06-10|1994-01-14|国際試薬株式会社|Toilet tool|
    US6087121A|1997-07-11|2000-07-11|Mayo Foundation For Medical Education And Research|Chemiluminescent detection of heme proteins in biological samples|
    WO2000066005A1|1999-05-03|2000-11-09|Exact Laboratories, Inc.|Stool specimen collector|
    US7223604B1|2002-09-27|2007-05-29|Science & Technology Corporation @ Unm|Methods and kits for the detection of erythrocytes|
    US7235404B2|2005-05-04|2007-06-26|Beckman Coulter, Inc.|Cyanide-free lytic reagent composition and method of use for hemoglobin and white blood cell measurement|
    EP1938756A1|2006-12-29|2008-07-02|Qiagen GmbH|Method and materials for triggered release of a biological sample|
    EP1939604A1|2006-12-29|2008-07-02|Preanalytix GmbH|Device for collecting and triggered release of a biological sample|
    CN102313813B|2008-05-20|2014-01-15|北京莱尔生物医药科技有限公司|Integration method for enriching and detecting rare cells from biological fluid samples|
    JP5761660B2|2009-05-29|2015-08-12|国立大学法人九州工業大学|Method for quantifying metal protoporphyrin complex and enzyme sensor used therefor|
    WO2013068885A1|2011-11-07|2013-05-16|Koninklijke Philips Electronics N.V.|Detection apparatus for determining a state of tissue|
    US8821811B2|2012-09-26|2014-09-02|Google Inc.|In-vitro contact lens testing|
    US9726679B2|2015-07-28|2017-08-08|King Saud University|Spectral method for quantifying hemoglobin fragility caused by smoking|
    US20170112477A1|2015-10-21|2017-04-27|Boston Scientific Scimed, Inc.|Tissue sample device and methods|
    MX369254B|2017-03-06|2019-09-24|Centro De Investig Cientifica Y De Educacion Superior De Ensenada Baja California Cicese|System for handling high-viscosity biological samples.|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    US06/190,399|US4378971A|1980-09-24|1980-09-24|Method and apparatus for quantitatively determining the level of hemoglobin in a biological sample|
    [返回顶部]